• 5-Ethynyl-2'-deoxyuridine: Precision in Cell Proliferation A

  2026-04-30

  5-Ethynyl-2'-deoxyuridine (5-EdU) enables rapid, antibody-free detection of S phase DNA synthesis, streamlining cell proliferation assays and tumor growth research. Its click chemistry workflow preserves cell integrity and is ideal for high-throughput applications, outperforming traditional thymidine analogs in sensitivity and convenience.

• LLY-507: Selective SMYD2 Inhibitor for Cancer and Fibrosis R

  2026-04-30

  LLY-507 is a highly potent and selective SMYD2 inhibitor characterized by subnanomolar activity and remarkable selectivity for SMYD2 over other methyltransferases. This article compiles validated evidence for its mechanism, selectivity, and preclinical impact in cancer and fibrosis models, clarifying its workflow parameters and boundaries for translational research.

• GCL Homolog Controls Early Spermatogenesis in Macrobrachium

  2026-04-29

  Molcho et al. (2024) provide the first functional characterization of a germ cell-less (GCL) homolog in the giant prawn, revealing its pivotal role in early spermatogenesis. Their findings clarify conserved mechanisms of gonad development in crustaceans and open practical avenues for sterile population management.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Workf

  2026-04-29

  Oseltamivir acid delivers robust, quantifiable inhibition of influenza virus replication and empowers translational workflows in both virology and oncology research. This article details precise protocol enhancements, troubleshooting strategies, and the practical impact of recent pharmacokinetic advances—cementing Oseltamivir acid’s value for innovative antiviral and cancer studies.

• Strategic Lysosome Labeling: Insights for Translational Rese

  2026-04-28

  This thought-leadership article spotlights Lyso-Tracker Red as a transformative tool for live-cell lysosome analysis, blending mechanistic insight with actionable guidance for translational researchers. By integrating evidence from recent advances—including the targeting of tumor-associated bacteria in immuno-oncology—this piece moves beyond conventional product summaries, offering a strategic roadmap for leveraging lysosomal biology in disease modeling and therapeutic innovation.

• Translating mRNA Stability into Breakthroughs: EZ Cap™ EGFP

  2026-04-28

  Explore how advanced capped mRNA technologies—exemplified by EZ Cap™ EGFP mRNA (5-moUTP)—are redefining the boundaries of translational research, from precise gene expression to immune evasion. This article connects mechanistic insights, recent breakthroughs in immunotherapy, and practical protocol guidance to empower researchers innovating at the cutting edge of mRNA delivery and evaluation.

• Biodegradable IR-1061 Polymer Nanoparticles for Deep NIR-II

  2026-04-27

  This study introduces a straightforward method to encapsulate the near infrared fluorescent dye IR-1061 in biodegradable PEG-b-PCL polymer micelles, enabling stable over-1000 nm (NIR-II) fluorescence for deep tissue in vivo imaging. The approach addresses limitations of previous inorganic nanomaterials and complex encapsulation protocols, offering a clinically relevant, biocompatible alternative.

• Prochlorperazine: Beyond Antiemesis—A Platform for Melanoma

  2026-04-27

  Explore Prochlorperazine, a dopamine D2 receptor antagonist, as more than an antiemetic—uncover its unique mechanisms in melanoma research and viral entry inhibition. This article offers a deep dive into advanced applications, protocol parameters, and evidence-based insights distinct from existing resources.

• Kir2.1 Inhibition Reduces PASMC Proliferation in PH Models

  2026-04-26

  This study demonstrates that targeted inhibition of Kir2.1 potassium channels significantly reduces pulmonary artery smooth muscle cell (PASMC) proliferation and migration, critical processes in pulmonary hypertension and vascular remodeling. Using ML133, a selective Kir2.1 inhibitor, the research uncovers the mechanistic link between Kir2.1 activity, the TGF-β1/SMAD2/3 pathway, and PASMC behavior, with implications for cardiovascular research.

• Scenario-Driven Solutions: Basic Protein Native PAGE Gel Kit

  2026-04-25

  This article delivers a scenario-driven, evidence-based guide to tackling laboratory workflow challenges in native protein gel electrophoresis, focusing on the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0), SKU K4142. Drawing on real laboratory questions and experimental bottlenecks, we demonstrate how this kit enables reproducible, activity-preserving separation of acidic proteins for advanced cell viability, proliferation, and cytotoxicity assays. Readers gain actionable insights rooted in validated best practices and recent literature.

• Translating Mechanistic qPCR Precision into Oncology Biomark

  2026-04-24

  This thought-leadership article explores the mechanistic and translational advantages of HotStart™ Universal 2X FAST Green qPCR Master Mix (Rox) in dye-based quantitative PCR workflows, with a special focus on gene expression analysis in biomarker discovery for fibrolamellar carcinoma. Drawing on recent peer-reviewed studies and benchmarking evidence, it connects molecular innovation to strategic guidance for translational researchers, while providing protocol insights and an outlook on the evolving landscape.

• Ceruletide (Caerulein): Precision Modeling of Pancreatic Fib

  2026-04-24

  Explore how Ceruletide (Caerulein) empowers advanced, reproducible models of pancreatic fibrosis and gastrointestinal physiology. Uncover the latest mechanistic insights and practical assay considerations that set this analysis apart in digestive disorder research.

• Novel Brassinosteroid Analogs: Structure–Activity Insights v

  2026-04-23

  This study reports the synthesis and activity profiling of new 3-dehydroteasterone derivatives with 23,24-dinorcholanic side chains and benzoate groups at C-22, using rigorous plant bioassays. The work clarifies how specific structural modifications influence brassinosteroid activity, offering critical structure–activity relationship data for researchers developing plant growth regulators or benchmarking bioactive analogs.

• Calpain Inhibitor I, ALLN: Technical Guidance for Apoptosis

  2026-04-23

  Calpain Inhibitor I (ALLN, SKU A2602) provides a selective approach for inhibiting calpain and cathepsin proteases in apoptosis and ischemia-reperfusion injury models. Researchers should apply this compound where targeted protease inhibition is required, following strict solubility and storage protocols. It is not recommended for diagnostic or clinical use due to its research-only designation.

• Sodium-Induced Mitochondrial Dysfunction Drives NECSO Cell D

  2026-04-22

  The study by Qiao et al. uncovers how sodium influx, via TRPM4 activation, disrupts mitochondrial energy metabolism, leading to necrosis by sodium overload (NECSO). Their mechanistic insights clarify how mitochondrial Na+ and Ca2+ dysregulation impairs oxidative phosphorylation and the TCA cycle, with broad implications for apoptosis research and disease modeling.

470 records 21/32 page Previous Next First page 上5页 2122232425 下5页 Last page